GlassScriptPhysician profile
Stephen Mahoney
NPI 1023496940
$2,067.72
in general payments reported to CMS, 2019-2025
17 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $708 · 2023: $447 · 2024: $540 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $715.93 | 2022-2025 | Interstim |
| Intuitive Surgical, INC. | $241.43 | 2022-2024 | |
| Davol INC. | $176.31 | 2022-2025 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $163.50 | 2022-2024 | |
| W. L. Gore & Associates, INC. | $150.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $122.04 | 2023 | |
| Myriad Genetic Laboratories, INC. | $114.89 | 2022-2024 | Myrisk |
| Stryker Corporation | $102.70 | 2023-2024 | Spy-Phi System |
| Abbvie INC. | $87.76 | 2023-2025 | |
| Ethicon US, LLC | $62.59 | 2023 | Enseal, Echelon Circular |
| Axonics, INC. | $25.28 | 2024 | Axonics |
| Innovation Technologies INC | $23.47 | 2023 | Irrisept |
| Thd America, INC. | $20.15 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $17.64 | 2023 | Andexxa |
| Acera Surgical, INC. | $15.39 | 2025 | Restrata Wound Matrix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14.40 | 2025 | Spyglass Discover |
| Braintree Laboratories, INC. | $14.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Mahoney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.